ACPE Accredited Continuing Education for Pharmacists and Pharmacy Technicians
Naloxone: Closing the Access Gap Webcast– 1.0 CE
Opioid overdose deaths in the United States have risen dramatically in the last decade, largely driven by illicit fentanyl and other synthetic opioids. Naloxone, a mu-opioid receptor antagonist, rapidly and safely reverses the effects of an opioid overdose. Increased access to naloxone has been identified by the US DHHS and the Surgeon General as a key initiative for reducing opioid overdose deaths. However, less than 1 in10 patients who could benefit from naloxone have access to this life-saving antidote. Healthcare professionals can lead the way toward closing the naloxone access gap.
This activity provides participants with data describing opioid-related harms in the United States, discuss cutting-edge public health and pharmacy-driven initiatives for increasing access to naloxone, and identify key research findings that pertain to strategies for identifying patients at risk for unintentional overdose and increasing access to life-saving harm reduction interventions.
At the conclusion of this continuing education activity, the participant will be able to:
- Describe barriers to naloxone access and alternative distribution models in the United States.
- Evaluate current strategies to expand access to naloxone, naloxone devices, and proposed alternative models.
- Develop patient care strategies for increasing access to naloxone andother harm-reduction resources
AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AchieveCE is an approved provider of nursing continuing professional development by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. GNA Approved Provider Number is 4003268. AchieveCE is an approved provider from July 14, 2022 to July 14, 2025.
William Eggleston, PharmD, DABAT received his Doctor of Pharmacy degree from Wilkes University and completed a fellowship in clinical toxicology and emergency medicine at SUNY Upstate Medical University and with the Upstate New York Poison Center in Syracuse, N.Y.
Financial Support Disclosure
This activity was developed by AchieveCE free of any commercial support. William Eggleston, PharmD, DABAT has no actual or potential conflicts of interest to disclose.
Pete Kreckel, RPh, and Jaimini Patel, RPh, planner for this educational event, also have no relevant financial relationship(s) with ineligible companies to disclose.
Level 2. Basic Application of Skills and Concepts
Home Study Webcast
1.0 Contact Hour
Disease State Management / Drug Therapy
Universal Activity Number
Activity Release Date
October 19, 2022
Activity Expiration Date
October 19, 2025
Handout Download Link(s)
Already a Member?
Requirements for Credit
Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CPE Monitor and/or CE Broker if your license information is entered properly in your profile.
CE Broker Reporting
If you are licensed under a board supported by CE Broker, feel free to log into your CE Broker account to view your reported courses or to contact their support staff.
Windows 8.1, Windows 10
Mac OS X 10.1 or higher
iOS 10+, Android 4.3+
Google Chrome, Microsoft Edge, Mozilla Firefox
Adobe Acrobat Reader
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
Get Unlimited CE!
Get unlimited CE for one low annual fee.
Save time and money by becoming a member!